1. The experimental antitumor properties of three congeners of the acridylmethanesulphonanilide (AMSA) series;Cain;Eur J Cancer,1974
2. m-AMSA: Methanesulfon-m-anisidide, 4′-(9-acridinylamino) NSC-249992—Clinical Brochure,1977
3. Interaction of 4′-(9-acridinyl-amino) methanesulfon-m-anisidide with DNA and inhibition of carnavirus reverse transcriptase and cellular nucleic acid polymers;Gormley;Cancer Res,1978
4. Phase I study of methane-sulfonamide, N-(4-(9-acridinylamino)-3-methoxyphenyl)-(m-AMSA), using a single-dose schedule;Von Hoff;Cancer Treat Rep,1978
5. Phase I clinical investigation of 4′-(9-acridinylamino)methanesulfon-m-anisidide (NSC-249992), a new acridine derivative;Legha;Cancer Res,1978